17α-Methyl-19-norprogesterone (developmental code name H-3510), also known as 17α-methyl-19-norpregn-4-ene-3,20-dione, is a progestin which was never marketed.[1][2][3] It is a derivative of progesterone, and is the combined derivative of 17α-methylprogesterone and 19-norprogesterone.[1] The drug is the parent compound of a subgroup of the 19-norprogesterone group of progestins, which includes demegestone (the δ9 derivative), promegestone (the δ9 and 21-methyl derivative), and trimegestone (the δ9, 21-methyl, and 21-hydroxyl derivative).[4]
^ abWeiss MJ, Schaub RE, Allen Jr GR, Poletto JF, Pidacks V, Conrow RB, Coscia CJ (1964). "The formation of steroid enolate anions by reductive procedures". Tetrahedron. 20 (2): 357–372. doi:10.1016/S0040-4020(01)93223-5. ISSN0040-4020.
^Raynaud JP, Philibert D, Azadian-Boulanger G (1974). "Progesterone-Progestin Receptors". In Elsimar Coutinho (ed.). Physiology and Genetics of Reproduction, part A. Basic Life Sciences. Vol. 4. pp. 143–160. doi:10.1007/978-1-4684-2889-6_10 (inactive 1 November 2024). ISBN978-1-4684-2891-9. PMID4374925.{{cite book}}: CS1 maint: DOI inactive as of November 2024 (link)